指南与共识泌尿生殖腹部MRUS

指南之指南:前列腺癌局灶治疗是否该达成共识?

Guidelines of guidelines: focal therapy for prostate cancer, is it time for consensus?
指南 / 共识 · BJU Int · 2022-09-27

该文汇总分析了欧洲泌尿外科学会等多学科指南以及2015年以来的共识声明,评估前列腺癌局灶治疗的推荐现状。结果显示缺乏长期随机数据,国际泌尿指南强调需更多高质量临床试验,共识与立场声明异质性大。全球公认的局灶治疗规划、技术和随访指南尚未确定。

要点

  • 前列腺癌局灶治疗缺乏长期随机对照数据,现有推荐证据等级不高。
  • 国际指南强调需开展高质量临床试验,关注肿瘤学与毒性终点。
  • 现有共识与立场声明异质性大,尚无全球统一的规划、技术及随访指南。

核心结论

  • 前列腺癌局灶治疗尚缺乏长期随机数据,全球公认的规划、技术和随访指南仍未确定。
  • 国际泌尿指南强调需更多高质量临床试验,以稳健的肿瘤学和毒性终点评估局灶治疗。
  • 现有共识和立场声明异质性大,需长期随访研究以统一局灶治疗的管理和随访。

研究设计与样本

  • 该文为指南/共识汇总分析,检索了欧洲泌尿外科学会-欧洲核医学协会-欧洲放射肿瘤学会-欧洲泌尿生殖放射学会-国际泌尿病理学会-国际老年肿瘤学会及美国泌尿外科学会-美国放射肿瘤学会-泌尿肿瘤学会指南中关于局灶治疗的推荐。
  • 通过PubMed和Ovid Medline检索2015年以来的英文共识声明,并手动检索纳入文献的参考文献列表。

临床应用与阅片要点

  • 日常阅片和报告中应了解前列腺癌局灶治疗缺乏统一指南,对治疗前后影像评估需谨慎解释。
  • 关注局灶治疗相关影像表现时,需结合多学科共识和临床试验背景,避免过度解读。

局限性

  • 原文指出缺乏长期随机数据,共识和立场声明异质性大。
  • 仅纳入2015年以来的英文文献,可能存在语言和发表偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To provide a summary and discussion of international guidelines, position statements and consensus statements in relation to focal therapy (FT) for prostate cancer (PCa).

METHODS: The European Association of Urology-European Association of Nuclear Medicine-European Society for Radiotherapy and Oncology-European Society of Urogential Radiology-International Society of Urological Pathology-International Society of Geriatric Oncology and American Urological Association-American Society for Radiation Oncology-Society of Urologic Oncology guidelines were interrogated for recommendations for FT. PubMed and Ovid Medline were searched for consensus statements. Only studies in English since 2015 were included. Reference lists of the included articles were also interrogated and a manual search for studies was also performed.

RESULTS: Our results showed a lack of long-term randomised data for FT. International Urological guidelines emphasised the need for more high-quality clinical trials with robust oncological and toxicity outcomes. Consensus and positions statements were heterogenous.

CONCLUSION: A globally accepted guideline for FT planning, technique and follow-up are still yet to be determined. Well-designed studies with long-term follow-up and robust clinical and toxicity endpoints are needed to improve our understanding of FT and create uniform guidelines to streamline management and follow-up.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Ong, Chen, Grummet, et al. Guidelines of guidelines: focal therapy for prostate cancer, is it time for consensus? BJU Int. 2022. PMID: 36083229. doi:10.1111/bju.15883

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。